Mylan Sells Entire 5.64% Stake in Biocon; Morgan Stanley, Goldman Sachs, Citigroup and 33 Other Investors Acquire Shares
15 july 2026 (Navroze Bureau) : Global pharmaceutical company Mylan has completely exited Biocon Ltd. by selling its entire 5.64% stake through a block deal. The shares were acquired by a consortium of 36 institutional investors, […]

